Ikarian Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-17,805
| Closed | -$747K | – | 112 |
|
|
2023
Q1 | $747K | Sell |
17,805
-50,000
| -74% | -$2.1M | 0.17% | 62 |
|
|
2022
Q4 | $2.59M | Sell |
67,805
-90,000
| -57% | -$3.43M | 0.62% | 28 |
|
|
2022
Q3 | $6.18M | Buy |
+157,805
| New | +$6.18M | 1.23% | 11 |
|
|
2022
Q2 | – | Sell |
-249,907
| Closed | -$8.27M | – | 153 |
|
|
2022
Q1 | $8.27M | Buy |
+249,907
| New | +$8.27M | 1.09% | 8 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 179 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 187 |
|
|
2021
Q2 | – | Sell |
-91,151
| Closed | -$6.82M | – | 211 |
|
|
2021
Q1 | $6.82M | Buy |
91,151
+25,000
| +38% | +$1.87M | 0.23% | 31 |
|
|
2020
Q4 | $5.72M | Sell |
66,151
-50,000
| -43% | -$4.33M | 0.25% | 31 |
|
|
2020
Q3 | $7.1M | Sell |
116,151
-85,000
| -42% | -$5.2M | 0.51% | 13 |
|
|
2020
Q2 | $8.36M | Buy |
201,151
+18,100
| +10% | +$753K | 0.67% | 13 |
|
|
2020
Q1 | $5.26M | Buy |
183,051
+50,051
| +38% | +$1.44M | 0.4% | 19 |
|
|
2019
Q4 | $9.6M | Buy |
+133,000
| New | +$9.6M | 1.56% | 2 |
|